Real-world evidence and multi-omics insights into differential immunotherapy responses between primary and metastatic sites
Completed
This study examines how tumors in different metastatic organs respond to immune checkpoint inhibitor (ICB) therapy in real-world clinical practice. ICB therapy helps the immune system recognize and attack cancer cells, but treatment responses may vary depending on where the cance…
Sponsor: Wenlong Zhong, MD
Last updated Jun 16, 2026 12:53 UTC